Spiriva Respimat 2.5 mcg
Spiriva Respimat 2.5 mcg is a medicine authorised by Swissmedic under authorisation number 67396. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 May 2019 and the authorisation is valid without a time limit. ATC code R03BB04 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 67396 |
|---|---|
| Name | Spiriva Respimat 2.5 mcg |
| Full name | Spiriva Respimat 2.5 mcg, Lösung zur Inhalation (wiederverwendbar) |
| Authorisation holder | Boehringer Ingelheim (Schweiz) GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03BB04 |
| First authorisation | 02 May 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Spiriva Respimat 2.5 mcg, Lösung zur Inhalation (wiederverwendbar) | B | 02 May 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Stück | R03BB04 | 03.04.3. | B |
| 2 | 3 | Stück | R03BB04 | 03.04.3. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Spiriva Respimat 2.5 mcg authorised in Switzerland?
Yes. Spiriva Respimat 2.5 mcg is authorised by Swissmedic under authorisation number 67396, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Spiriva Respimat 2.5 mcg have?
Spiriva Respimat 2.5 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Spiriva Respimat 2.5 mcg?
The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.